Matrix Metalloproteinases: A challenging paradigm of cancer management

A Alaseem, K Alhazzani, P Dondapati, S Alobid… - Seminars in cancer …, 2019 - Elsevier
Matrix metalloproteinases (MMPs) are members of zinc-dependent endopeptidases
implicated in a variety of physiological and pathological processes. Over the decades …

[PDF][PDF] Reactive oxygen species in tumor progression

P Storz - Front biosci, 2005 - researchgate.net
Introduction 3. Reactive oxygen species in tumor growth and cellular survival 4. Reactive
oxygen species in cell motility and metastasis formation 5. Generation of reactive oxygen …

Matrix metalloproteinases: their functional role in lung cancer

N Merchant, GP Nagaraju, B Rajitha… - …, 2017 - academic.oup.com
Lung malignancy is the foremost cause of cancer-related deaths globally and is frequently
related to long-term tobacco smoking. Recent studies reveal that the expression of matrix …

Mitochondrial redox control of matrix metalloproteinases

KK Nelson, JA Melendez - Free Radical Biology and Medicine, 2004 - Elsevier
Reactive oxygen species (ROS) are constantly generated in aerobic organisms during
normal metabolism and in response to both internal and external stimuli. Imbalances in the …

Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?

P Micke - Lung cancer, 2004 - Elsevier
Stroma cells, together with extracellular matrix components, provide the microenvironment
that is pivotal for cancer cell growth, invasion and metastatic progression. Characteristic …

Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases

MM Gueders, JM Foidart, A Noel, DD Cataldo - European journal of …, 2006 - Elsevier
In healthy lung, Matrix Metalloproteinases (MMPs) and their physiological inhibitors, tissue
inhibitors of matrix metalloproteinases (TIMPs), are produced in the respiratory tract by a …

Matrix metalloproteinases in lung diseases

H Ohbayashi - Current Protein and Peptide Science, 2002 - ingentaconnect.com
Matrix metalloproteinases (MMPs) are a pivotal family of zinc enzymes responsible for
degradation of the extracellular matrix (ECM) components including basement membrane …

Phase III study of matrix metalloproteinase inhibitor prinomastat in non–small-cell lung cancer

D Bissett, KJ O'Byrne, J Von Pawel… - Journal of Clinical …, 2005 - ascopubs.org
Purpose Matrix metalloproteinases (MMPs) degrade extracellular proteins and facilitate
tumor growth, invasion, metastasis, and angiogenesis. This trial was undertaken to …

Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of …

FA Shepherd, G Giaccone, L Seymour… - Journal of clinical …, 2002 - ascopubs.org
PURPOSE: Increased expression of metalloproteinases is associated with poor prognosis in
small-cell lung cancer (SCLC). This trial was undertaken to determine whether adjuvant …

Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model

Y **a, N Yeddula, M Leblanc, E Ke, Y Zhang… - Nature cell …, 2012 - nature.com
Lung cancer is one of the leading cancer malignancies, with a five-year survival rate of
only∼ 15%. We have developed a lentiviral-vector-mediated mouse model, which enables …